It’s important to note that malignant melanoma cancer is less common, but more deadly. If not caught early and allowed to spread to other organs, it can be fatal.

The CDC produced a article published by the Journal of the American Academy of Dermatology, focusing on melanoma surveillance, trends, and survival rates. Many of the studies used data from CDC’s National Program of Cancer Registries and the National Cancer Institute’s Surveillance, Epidemiology and End Results program, covering the largest percentage of the U.S. population ever studied.

More than 45,000 cases of melanoma occurred in 45 states and the District of Columbia each year between 2004 and 2006, according to the report. Melanoma is the deadliest type of skin cancer, causing about 8,000 deaths in the U.S. each year.

Significant Findings
Deaths caused by melanoma accounted for $3.5 billion in lost productivity each year. A person who died of melanoma between 2000 and 2006 died 20 years prematurely, compared to 17 years from other cancers.

Melanoma rates were higher among white, Hispanic females aged 50 and younger, and Asian/Pacific Islander females aged 40 and younger, compared to their male counterparts. This study also found that Hispanics, American Indians/Alaska Natives, and Asians were diagnosed with melanoma at younger ages than whites and blacks.

Melanoma incidence was higher among females than males, increased with age, and was higher in non-Hispanic whites than Hispanic whites, blacks, American Indians/Alaska Natives, and Asians/Pacific Islanders.

In 2005, 34% of adults had been sunburned in the past year, and in 2004, 69% of adolescents were sunburned during the previous summer.

Doctors are required by law to report melanomas to central cancer registries, but many dermatologists reported being unaware of reporting requirements.

About SIMSYS-MoleMate
The FDA approved SIMSYS-MoleMate Skin Imaging System, a non-invasive skin cancer screening procedure, is a significant advance in the early detection of potentially life threatening moles and lesions.

Physicians have found the SIMSYS-MoleMate Siascope hand-held device easy to learn and use, and that it rapidly provides accurate images of the pigment, blood, and collagen below the mole or lesion.

Now for the first time, physicians can more accurately evaluate suspicious moles and lesions in a non-invasive, pain-free way. Experts also believe it may reduce the need for time consuming and expensive biopsies. For more information about SIMSYS-MoleMate,

Contact:
MedX Health Corp.
(905) 670-4428
(888) 368-3112
info@medxhealth.com
www.simsys-molemate.com

Over the last twenty-five years, the incidence of melanoma has increased more than for any other major cancer in the US at an alarming rate. Worldwide, the incidence of melanoma is increasing faster than any other cancer with an approximate doubling of rates every 10-20 years in countries with white populations.

Although the incidence of melanoma increases with age, a third of all cases occur in people aged less than fifty years and it is the second most common cancer in the 20-39 age-group. The increasing incidence has been attributed to increases in UV exposure, both natural and artificial, and to associated advances in early diagnosis. Other risk factors include genetic predisposition, fair complexion, sunburn-susceptible skin types, and family history

In 2009, up to nineteen out of every twenty lesions referred to a skin specialist (dermatologist) by a GP under the two-week cancer standard were benign. Alternative approaches are therefore required to increase the precision of assessment of pigmented skin lesions in primary care and therefore reduce the number of unnecessary referrals of benign lesions. This will be beneficial not only in secondary care, but also to reduce unnecessary patient anxiety.

The MoleMate system is a small hand-held scanner linked to a computer program, which has been designed for use in general practices to help the doctor or nurse assess a mole. The system uses SIAscopy (a non-invasive scanning technique) to produce images of the mole. The images are then assessed and a decision made as to whether or not the mole should be referred and looked at in more detail by a dermatologist.

About SIMSYS-MoleMate
The FDA approved SIMSYS-MoleMate Skin Imaging System, a non-invasive skin cancer screening procedure, is a significant advance in the early detection of potentially life threatening moles and lesions.

Physicians have found the SIMSYS-MoleMate Siascope hand-held device easy to learn and use, and that it rapidly provides accurate images of the pigment, blood, and collagen below the mole or lesion.

Now, for the first time, physicians can more accurately evaluate suspicious moles and lesions in a non-invasive, pain-free way. Experts also believe it may reduce the need for time consuming and expensive biopsies. For more information about SIMSYS-MoleMate,

Contact:
MedX Health Corp.
(905) 670-4428
(888) 363-3112
info@medxhealth.com
www.simsys-molemate.com

Up until now, getting simply a more detailed look at the surface of the skin has been the aim of skin imaging techniques. However, better magnification does not automatically lead to better classification when it is still only the eye that decides, based on color and shape alone. Health practitioners who examine or treat the skin need an objective, rigorous and repeatable way of characterizing and diagnosing lesions that can be reproduced and matched or compared in other clinical settings. Such a method needs to generate images, but these images must be backed up with spectroscopic data. It is the spectroscopic data, rather than the images, that actually determine the parameters for diagnosis.

Better diagnosis can mean more timely and appropriate treatment, and reduce the number of false positives. In the US numbers there are around 2.5 million ‘excess’ excisions annually. Given these figures, it is not hard to imagine the impact that more accurate diagnosis could have on patient throughput and waiting lists. Better diagnosis can prevent disfigurement where cancer is not confirmed and, in the case of malignant melanoma, save lives.

Many doctors are now looking beyond traditional methods and seeking modern ways to aid their diagnosis and increase consultation efficiency, and many of them are using an advanced, clinically proven, non-invasive skin imaging technique called SIAscopy, Spectrophotometric

SIAscopy allows you to examine the skin to a depth of 2mm, and shows concentrations of hemoglobin, pigment and collagen. It is proving to be not only a valuable aid to diagnosis, but also a reliable method for obtaining objective data for baseline purposes or for referral.

Acne, eczema, psoriasis, warts and skin tumors are amongst the commonest of all human disorders. Thus it is hardly surprising that ‘skin diseases account for about 15 per cent of a general practitioner’s workload’ (Marks 2003). The skin is the body’s largest organ and highly complex in structure and function. Skin disorders can be general or localized in particular areas of the body. They are frequently instantly visible and can have devastating physical, emotional and psychological effects so fast and accurate diagnosis can be key to patient wellbeing and a successful treatment outcome.

A large number of skin conditions present as pigmented skin lesions, discolorations of areas of skin due to an underlying physiological problem. Pigmented skin lesions can be confined to the stratum corneum, or penetrate deeper into the epidermis and dermis, and may also expand upwards from the skin’s surface. They range from the benign to the life-threatening, and from those that are merely a nuisance to those that are completely debilitating.

The skin condition that requires the most urgent diagnosis and treatment is skin cancer. There are 32 types of skin tumor, from the benign, such as squamous cell papillomas and haemangioma, to the malignant, such as basal cell carcinoma and Kaposi’s sarcoma. The most dangerous form of skin cancer is malignant melanoma, which spreads either horizontally (superficial spreading malignant melanoma, SSMM) or vertically downwards (nodular malignant melanoma, NMM), the latter being the more immediately life-threatening. Malignant melanoma has a very high five-year survival rate if treated early, and prognosis is closely correlated with the depth to which the malignant melanoma has penetrated into the dermis.

The color of the skin is mostly due to the concentrations of pigment and hemoglobin, and it is changes in these constituents that lead to the appearance of pigmented skin lesions. Pigment is synthesized by melanocytes and darker areas of skin indicate higher pigment production (rather than greater numbers of melanocytes). Coloration due to hemoglobin relates not only to concentration but also to degree of oxygenation.

Aspects of skin lesions that aid in diagnosis include not only color (shade and tone), but also shape, how well-defined the edges of the lesion are, and size. Given the vast array of different types of skin lesions, it is not surprising that it can sometimes be difficult to distinguish between them. For instance, while some skin tumors have distinctive characteristics that make them more straightforward to diagnose, in many cases alternative conditions have to be ruled out. Seborrhoeic ketoses, for example, although easy to recognize, may be confused with ‘a pigmented cellular nevus, a pigmented basal cell carcinoma and, most importantly, with a malignant melanoma’ (Hunter et al, 2002).

Dermatologists address this difficulty in part through their extensive experience. They build up a mental database that enables them to arrive at their diagnosis by a process of comparison and elimination against similar conditions that they have diagnosed in the past. Scoring systems have been developed based on visible characteristics to aid the diagnostic process, but many of these have a large margin of error and this leads to significant numbers of false positive results.

Confirmation of this visual method of diagnosis can only be provided by microscopic analysis, which means removing some of the skin for

examination (Biopsy).

Biopsy is particularly common in cases of suspected malignant melanoma, due to the recognized risks of leaving a potential malignancy untreated. Excision includes a margin of skin surrounding the suspected melanoma, typically at least 2cm of skin around a melanoma of 1cm diameter

The expression, ‘if in doubt, cut it out’, is a familiar one, and typically one would expect the patient to prefer this option for certainty of a cure. However, melanoma is linked to exposure to the sun; therefore it is not surprising that the face, hands and feet are the most likely sites for melanomas.

Large excisions may disfigure the patient, and accuracy in diagnosis can go a long way towards preventing unnecessary scarring and disfigurement. Given that the ratio of biopsies performed to malignant melanomas confirmed can be as high as 100:1, more accurate diagnosis can also have a considerable impact on the efficient use of a clinician’s time and resources skin lesions, giving the practitioner a better view of color distribution, shape and the margins of the lesion.

Dermatoscopy is a specialized form of illuminated magnification, using a fluid (mineral oil, alcohol or water) to eliminate surface reflection from the skin and magnifying the lesion by a factor of 10. This method requires formal training, but the trained practitioner is then better able to assess visually pigmented structures in the epidermis and superficial dermis. Dermatoscopy is combined with digital photography to give the practitioner a record of each lesion at each visit. Automated scoring systems, such as ABCDE, compare dermatoscopic images against a large database for best fit.

The newest aid in the diagnosis of pigmented skin lesions is SIAscopy, or Spectrophotometric Intracutaneous Analysis, which provides spectroscopic data about a skin lesion without the need for laboratory analysis and so takes the subjectivity out of clinical examination. SIAscopy is unique in that it allows the practitioner to view beneath the surface of the skin. It uses white light and sophisticated software to provide independent views of pigment, dermal pigment, hemoglobin and collagen in the stratum corneum, epidermis and dermis to a depth of 2mm. The images (SIAscans) can be viewed separately or overlaid, to demonstrate how the features relate to one another, and help to make any necessary excision more precise by showing the exact size of a lesion. SIAscopy is a completely safe, non-invasive and painless technique, which makes it ideal for analyzing and monitoring many skin conditions, including skin cancers, psoriasis, acne, eczema, skin de-pigmentation, skin aging and scars.

The technique is available in two methods, contact and non-contact SIAscopy. How SIAscopy works is described in more detail below.

How SIAscopy works

SIAscopy measures the amount of hemoglobin, pigment, collagen in the stratum corneum, epidermis and dermis to a depth of 2mm, and identifies whether pigment is present in the epidermis or the dermis.

The information is presented to the practitioner as SIAscans, which show how these components vary over the skin. SIAscopy makes use of the way light interacts with skin – the way it scatters or bounces and the amount absorbed by cells and other structures – and how this varies for different wavelengths or colors of light. Due to the multi-layered structure of the skin, and because the most prominent chromophores have slowly varying spectral properties, it is possible to generate models which can predict the method of light transport within skin. This allows us to analyze the skin using broadband spectrophotometric techniques.

By sending light into the skin and measuring how it emerges back out, SIAscopy is able to determine the nature and position of many of the different cells and structures within the skin. Different primary wavelengths of light are shone into the skin in turn. An imaging chip records the light remitted from the skin at each pixel, giving an image representing the amount of light leaving the skin for each of the four wavelengths used. Cross polarizer are used to remove any scattering from the surface of the skin.

In order to generate the model, simulations are run for hundreds of thousands of different combinations of hemoglobin, pigment, collagen and dermal pigment. The result of each simulation represents how the camera would respond if it was to image the corresponding combination of skin chromophores. This information is stored, and then interrogated during each scan in order to generate SIAscans. Each SIAscan is a bitmap representing the concentration of each chromophore on every pixel. Each scan is made up of more than 1.5 million measurements.

About SIMSYS-MoleMate
The FDA approved SIMSYS-MoleMate Skin Imaging System, a non-invasive skin cancer screening procedure, is a significant advance in the early detection of potentially life threatening moles and lesions.

Physicians have found the SIMSYS-MoleMate Siascope hand-held device easy to learn and use, and that it rapidly provides accurate images of the pigment, blood, and collagen below the mole or lesion.

Now, for the first time, physicians can more accurately evaluate suspicious moles and lesions in a non-invasive, pain-free way. Experts also believe it may reduce the need for time consuming and expensive biopsies.

For more information about SIMSYS-MoleMate, contact:
MedX Health Corp.
(905) 670-4428
(888) 363-3112
info@medxhealth.com
www.simsys-molemate.com

Picture this:  You’re lying out on the beach enjoying the beautiful weather, a cold drink and the company of some friends. And because you’re a pretty good multitasker, you have no problem tapping into the conversation about the cute boys as well as listen to music…but you could be doing a third thing if you’re not careful – neglecting your skin’s health.

With the summer season fast approaching, there’s an uncomfortable topic I need to discuss with you. I know, I know, it’s like that awkward sex talk you get when you’re thirteen that you never want to hear again. I promise to make this as fast and painless as possible for you.

1. Skin cancer is the most common form of cancer in the United States. More than 3.5 million skin cancers in over two million people are diagnosed annually.
-That’s more than 800 students at UCF alone.

2. One in five Americans will develop skin cancer in the course of a lifetime.
-That’s 60 people in your lecture hall auditorium.

3. Nearly 800,000 Americans are living with a history of melanoma, and 13 million are living with a history of nonmelanoma skin cancer, typically diagnosed as basal cell carcinoma or squamous cell carcinoma.
-Melanoma is the most dangerous type of skin cancer if not detected early in its course.

4. Melanoma accounts for less than five percent of skin cancer cases, but it causes more than 75 percent of skin cancer deaths.

Okay now that that’s over, what can we do about it?
-Seek the shade
-SPF 15 and up! Go with 30 when in extended exposure.
-Avoid tanning beds.
-Look for both UVA and UVB (broad spectrum) protection in your sunscreen.
-Perform a monthly self-examination of skin
-Once a year visit your dermatologist to have a professional skin check-up.

Picture this: You’re relaxing at the beach on a vacation with your family. You love the cool breeze coming in from the shore – but now you are the proud parent of the two beautiful children that are having a great time playing in the sand. Without your knowledge of skin protection, you may have never made it this far…unfortunately the fate of so many others.

With skin cancer, knowing is preventing. Get people in the know and maybe you could save their life.

About SIMSYS-MoleMate

The FDA approved SIMSYS-MoleMate Skin Imaging System, a non-invasive skin cancer screening procedure, is a significant advance in the early detection of potentially life threatening moles and lesions.

Physicians have found the SIMSYS-MoleMate Siascope hand-held device easy to learn and use, and that it rapidly provides accurate images of the pigment, blood, and collagen below the mole or lesion.

Now, for the first time, physicians can more accurately evaluate suspicious moles and lesions in a non-invasive, pain-free way. Experts also believe it may reduce the need for time consuming and expensive biopsies. For more information about

SIMSYS-MoleMate,

Contact:
MedX Health Corp.
(905) 670-4428
(888) 363-3112
info@medxhealth.com
www.simsys-molemate.com

Burn notice: the dangers of tanning with an alarming increase in deadly skin cancer in young women, many states are considering a ban on indoor tanning for teens.

Caitlin knew the risks when she first started going tanning in college. Even so, once her friends began flocking to the tanning salon in the winter, she decided to try it out herself. “My mother is a health teacher—so I knew about the hazards—but I started going every couple of weeks anyway,” says the Brewster, New York, native. One day several years later, her mom noticed two overlapping freckles on Caitlin’s arm and urged her to get them checked out by a dermatologist. They turned out to be malignant melanoma, the deadliest form of skin cancer. “I felt so dumb for ignoring all the warnings my mom had given me,” says the now-24-year-old. Last year, she underwent surgery to remove the cancer, which has left behind a permanent scar; she’s now in remission.

One person dies of melanoma every hour in the United States, according to the Melanoma Research Alliance, and the number of melanoma cases is increasing among females ages fifteen to 39.

Want to know one of the biggest culprits behind this scary surge? Tanning beds: “They are carcinogenic [cancer-causing], and starting younger means you’re getting more cumulative damage from ultraviolet radiation,” says Mona Gohara, M.D., assistant clinical professor of dermatology at Yale School of Medicine. “Researchers are also speculating that because teens’ skin cells replicate faster, young people who are exposed to carcinogens may be more likely to get cancer later.” Earlier this year, California became the first state to ban tanning bed use for the under-eighteen set, and a handful of other states are considering similar laws.

The UV rays in tanning booths, which may be ten to fifteen times stronger than what you get from the sun, also boost one’s risk of developing the other two common types of skin cancers, squamous cell and basal cell carcinoma—especially if the person indoor-tanned during her high school and college years, according to the Skin Cancer Foundation. And it doesn’t take daily baking sessions to jeopardize your health: A teen’s first tanning bed experience increases her melanoma risk by a whopping 75 percent, according to the World Health Organization. In addition, recent studies have shown that indoor tanning may become addictive. “We believe the body may experience a chemical response to UV radiation, which would be a drug like addictive quality,” explains David E. Fisher, M.D., Ph.D., chief of dermatology at Massachusetts General Hospital. “If your mood is better afterward or if your mood gets worse when you haven’t been to the tanning bed that could be a big red flag.”

And despite what some ads might say, there’s no such thing as a safe tan. “When pigment production is stimulated by UV radiation, it means there’s been damage to the skin’s DNA,” says Fisher. According to a new investigative report on tanning salons by the U.S. House of Representatives Committee on Energy and Commerce, 78 percent of salons questioned in the study falsely claimed that tanning bed use was healthy for teens, and many of them specifically targeted girls in their advertisements by offering student discounts and special prom and back-to-school deals.

Thanks to the current generation of self-tanners and bronzers that are easy to use and natural in color, there’s no reason you need to roast in the sun or in a tanning bed to get a glow. Take it from Caitlin: “I ignored all the risks for vanity. Now, almost a year after my cancer surgery, I still find it hard to deal with emotionally,” she admits. “Tanning isn’t worth it.”

About SIMSYS-MoleMate

The FDA approved SIMSYS-MoleMate Skin Imaging System, a non-invasive skin cancer screening procedure, is a significant advance in the early detection of potentially life threatening moles and lesions.

Physicians have found the SIMSYS-MoleMate Siascope hand-held device easy to learn and use, and that it rapidly provides accurate images of the pigment, blood, and collagen below the mole or lesion.

Now, for the first time, physicians can more accurately evaluate suspicious moles and lesions in a non-invasive, pain-free way. Experts also believe it may reduce the need for time consuming and expensive biopsies. For more information about

SIMSYS-MoleMate,

Contact:
MedX Health Corp.
(905) 670-4428
(888) 363-3112
info@medxhealth.com
www.simsys-molemate.com
For more information on how to detect skin cancer, visit skincancer.org.

Any skin care professional will tell you that early diagnosis is key to successfully surviving skin cancer. In order to treat skin cancer successfully, you must find it early. And to do that, you and your doctor need to play a dual role in making an early skin cancer diagnosis.

“You should do a self-examination to check for skin cancer about once every month,” says Melissa Piliang, MD, a dermatologist at the Cleveland Clinic inOhio. “If you find anything suspicious, you need to let your doctor know. It’s also a good idea to have a complete examination by a doctor every one to two years.”

You should also talk to other doctors about your skin cancer risk, not just your dermatologist. “Melanomas can occur in places that are hard to see,” Dr. Piliang says. If you have any family history of melanoma, you should tell your gynecologist, dentist, and eye doctor so they can do special exams to look for melanoma.

What to Expect at the Dermatologist’s Office

Consequently, a skin cancer exam is not confined to any one part of your body. “Because skin cancer can be found anywhere, expect to be examined from head to toe, not just your hands and face,” says Piliang. Before you get to the dermatologist’s office, make sure you remove all nail polish, because melanoma can even grow under a fingernail.

A skin cancer exam also involves sharing your family medical history. Tell your doctor about any family history of skin cancer and about how much sun exposure you have had over the years. Some risk factors your doctor will want to know about include frequent sunburns as a child and any occupational exposure to pitch, coal tar, arsenic, creosote, or radium.

8 Steps in a Skin Cancer Self-Exam
To do this exam every month, you need a full-length mirror, a hand mirror, a chair or bench, and bright lighting:

1. Start with your face, nose, lips, and ears. Use a hand mirror to check the back of your neck.
2. Inspect your scalp using a blow dryer.
3. Check your hands and arms from each fingernail up to your elbows.
4. Face the full-length mirror and raise your arms over your head to see the underarm area.
5. Now look at your neck and chest area; women should examine the creases beneath the breasts.
6. Face away from the full-length mirror and use the hand mirror to look at your back and shoulders.
7. Now use the hand mirror to inspect the back of your buttocks and legs.
8. Finally, sit down and examine the insides of your legs, genitals, fronts of legs, feet, toes, toenails, and the soles of your feet.

Tell your doctor about the results of your most recent self-examination, and compare results to old exams. Also be sure to ask your doctor about any new skin growths and any changes in old skin growths, and if your doctor hasn’t heard of  MoleMate take this blog along with you to the doctor’s office.

About SIMSYS-MoleMate
The FDA approved SIMSYS-MoleMate Skin Imaging System, a non-invasive skin cancer screening procedure, is a significant advance in the early detection of potentially life threatening moles and lesions.

Physicians have found the SIMSYS-MoleMate Siascope hand-held device easy to learn and use, and that it rapidly provides accurate images of the pigment, blood, and collagen below the mole or lesion.

Now, for the first time, physicians can more accurately evaluate suspicious moles and lesions in a non-invasive, pain-free way. Experts also believe it may reduce the need for time consuming and expensive biopsies.

For more information about SIMSYS-MoleMate, contact:
MedX Health Corp.
(905) 670-4428
(888) 363-3112
info@medxhealth.com
www.simsys-molemate.com

A new study has revealed an alarming rise in melanoma among people aged 18 to 39: over the past 40 years, rates of this potentially deadly skin cancer grew by 800 percent among young women and 400 percent among young men. Researchers examined data on the 256 young adults in Olmstead County, MN, who were diagnosed with melanoma between 1970 and 2009. Between 1970 and 1979, just 16 new cases, or 4.8 cases per 100,000 people, were diagnosed. But in the decade ending December 31, 2009, 129 cases were recorded, an incidence rate of 30.8 cases per 100,000 people — an enormous jump from the 1970’s.

Although lifetime risk of melanoma is about 1.5 times greater in males than in females, among young people this pattern is reversed, as this Mayo Clinic Proceedings study demonstrated. The authors observed that Indoor ultraviolet (UV) tanning, which is much more popular among young women than young men, may account for the disproportionate increase in incidence among young women. UV rays emitted by tanning machines are cancer-causing, and Indoor ultraviolet (UV) tanners are 74 percent more likely to develop melanoma than those who have never tanned indoors; those who tan indoors just four times a year increase their risk of developing melanoma by 11 percent. Indoor tanners are also 2.5 times more likely to develop squamous cell carcinoma and 1.5 times more likely to develop basal cell carcinoma.

While the skyrocketing incidence figures are cause for major concern, the authors noted that death from the disease among young people is actually decreasing, due to earlier diagnosis; with more people aware of changes in their skin, and better diagnostic methods, melanomas are more frequently discovered at earlier stages, when they are easiest to treat

About SIMSYS-MoleMate
The FDA approved SIMSYS-MoleMate Skin Imaging System, a non-invasive skin cancer screening procedure, is a significant advance in the early detection of potentially life threatening moles and lesions.

Physicians have found the SIMSYS-MoleMate Siascope hand-held device easy to learn and use, and that it rapidly provides accurate images of the pigment, blood, and collagen below the mole or lesion.

Now, for the first time, physicians can more accurately evaluate suspicious moles and lesions in a non-invasive, pain-free way. Experts also believe it may reduce the need for time consuming and expensive biopsies.

For more information about SIMSYS-MoleMate, contact:
MedX Health Corp.
(905) 670-4428
(888) 363-3112
info@medxhealth.com
www.simsys-molemate.com

It can’t be said too many times. Your risk of getting skin cancer is real. More than 3.5 million cases of skin cancer are diagnosed in the United States each year. The good news is that you can reduce your risk by protecting your skin from ultraviolet radiation exposure.

The American Academy of Dermatology is offering tips on skin-cancer awareness tips and other resources to help you protect patients from the dangers of too much UV exposure.

Sun exposure is the most preventable risk factor for all skin cancers, including melanoma.

You can have fun in the sun and decrease your risk of skin cancer. Generously apply a broad-spectrum, water-resistant sunscreen with a Sun Protection Factor (SPF) of 30 or more to all exposed skin. “Broad-spectrum” provides protection from both ultraviolet A (UVA) and ultraviolet B (UVB) rays. Reapply approximately every two hours, even on cloudy days, and after swimming or sweating.

Wear protective clothing, such as a long-sleeved shirt, pants, a wide-brimmed hat, and sunglasses, where possible.

Seek shade when appropriate. Remember that the sun’s rays are strongest between 10 a.m. and 4 p.m. If your shadow appears to be shorter than you are, seek shade.

Use extra caution near water, snow, and sand because they reflect and intensify the damaging rays of the sun, which can increase your chances of sunburn.

Get vitamin D safely through a healthy diet that may include vitamin supplements. Don’t seek the sun.

Avoid tanning beds. Ultraviolet light from the sun and tanning beds can cause skin cancer and wrinkling. If you want to look tan, consider using a self-tanning product or spray, but continue to use sunscreen with it.

Check your birthday suit on your birthday. If you notice anything changing, growing, or bleeding on your skin, see a dermatologist. Skin cancer is very treatable when caught early.

About SIMSYS-MoleMate

The FDA approved SIMSYS-MoleMate Skin Imaging System, a non-invasive skin cancer screening procedure, is a significant advance in the early detection of potentially life threatening moles and lesions.

Physicians have found the SIMSYS-MoleMate Siascope hand-held device easy to learn and use, and that it rapidly provides accurate images of the pigment, blood, and collagen below the mole or lesion.

Now, for the first time, physicians can more accurately evaluate suspicious moles and lesions in a non-invasive, pain-free way. Experts also believe it may reduce the need for time consuming and expensive biopsies.

For more information about SIMSYS-MoleMate,

Contact:
MedX Health Corp.
(905) 670-4428
(888) 363-3112
info@medxhealth.com
www.simsys-molemate.com

In a news release by MedX Health Corp., which specializes in non-invasive laser light therapy and imaging systems, the company said the technology utilizes light and imagery systems to painlessly view two millimeters beneath a mole or lesion. The images are produced within seconds and physicians can determine whether the mole is dangerous and eliminate the need for skin biopsies.

MedX Health president Steve Guillen said that with 14 million Americans living with a history of melanoma and non-melanoma skin cancer, this technology is mostly for patients.

“For the first time we can look underneath a mole and see whether it really is cancer,” said Guillen. “We can quickly assess whether the lesion really needs to come out or not. Patients can tell within seconds whether it’s benign and go home pain and worry free.”

“It is a more sane way to provide information to the patients immediately. It is definitely a patient-centric technology,” said Guillen. “There is less surgery and less money involved, which makes both patients and their families happy.”

According to the American Cancer Society, when melanoma is detected early, the survival rate is about 99 per cent.

About SIMSYS-MoleMate
The FDA approved SIMSYS-MoleMate Skin Imaging System, a non-invasive skin cancer screening procedure, is a significant advance in the early detection of potentially life threatening moles and lesions.

Physicians have found the SIMSYS-MoleMate Siascope hand-held device easy to learn and use, and that it rapidly provides accurate images of the pigment, blood, and collagen below the mole or lesion.

Now, for the first time, physicians can more accurately evaluate suspicious moles and lesions in a non-invasive, pain-free way. Experts also believe it may reduce the need for time consuming and expensive biopsies.

For more information about SIMSYS-MoleMate, contact:
MedX Health Corp.
(905) 670-4428
(888) 363-3112
info@medxhealth.com
www.simsys-molemate.com

Rapid and accurate diagnosis can also be critical in the case of malignant melanoma, where early diagnosis is frequently life-saving, as well as reducing the number of unnecessary biopsies carried out where the eventual diagnosis is negative.

Traditional methods of diagnosing skin lesions have relied on experience and comparisons against previous examples, making them subjective and allowing for a large likelihood of false positives.

A new method, using SIAscopy, is objective, quick and easy to use. It provides independent views, SIAscans, of haemoglobin, pigment, dermal pigment and collagen to a depth of 2mm, and allows the practitioner to study these separately and in combination.

The distributions of these four skin components show characteristic pathological changes indicative of particular skin diseases. SIAscopy has enormous potential as an accurate and cost-effective diagnostic tool for any medical practitioner who treats patients with pigmented skin lesions.

About SIMSYS-MoleMate
The FDA approved SIMSYS-MoleMate Skin Imaging System, a non-invasive skin cancer screening procedure, is a significant advance in the early detection of potentially life threatening moles and lesions.

Physicians have found the SIMSYS-MoleMate Siascope hand-held device easy to learn and use, and that it rapidly provides accurate images of the pigment, blood, and collagen below the mole or lesion.

Now, for the first time, physicians can more accurately evaluate suspicious moles and lesions in a non-invasive, pain-free way. Experts also believe it may reduce the need for time consuming and expensive biopsies.

For more information about SIMSYS-MoleMate, contact:
MedX Health Corp.
(905) 670-4428
(888) 363-3112
info@medxhealth.com
www.simsys-molemate.com